Atropine Sulfate Injection, Solution
Product Images NDC 0404-9784

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 0404-9784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
This text provides a reference for administering doses to adults in various medical situations such as antisialagogue, antivagal, organophosphorus poisoning, muscarinic mushroom poisoning, and bradyasystolic cardiac arrest. It outlines specific dose ranges and timing for each condition, guiding healthcare professionals in treatment protocols.*
FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
This text provides information about Atropine injection, USP in a strength of 0.5mg/5mL. It comes in unit packages of 10, 5mL single-dose glass syringes. The National Drug Code (NDC) for this product is 70121-1705-1. It is important for concentration and strength evaluation.*
FDA Label Image

Image3.jpg (Image3)

Image3.jpg (Image3)
Description: The text provides information on Atropine strength and packaging options. Atropine is available in 1mg/10mL concentration. The product is presented as single-dose glass syringes, with different packaging options including a package of 10 syringes and a package of 24 syringes. Each syringe has a concentration of 1mg/ml. The NDC numbers for the product are 70121-1706-2 for the package of 10 syringes and 70121-1706-4 for the package of 24 syringes.*
FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
This text is a description of A!ru ine Sulfate 0.1 mg/mL injection, USP, in a single-dose syringe for intravenous use. The text includes handling instructions, storage conditions, manufacturer information, and a caution to keep out of children's reach. It also mentions checking the syringe for damage before use and using aseptic technique. The product should be discarded if the package is damaged. For complete product and expiration date information, refer to the manufacturer's insert. Packaged by Henry Schein, Inc., the original manufacturer is MirAmneal Pharmaceuticals LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.